Panacee Hospital Rama 2 - Integrative Chronic Disease & Regenerative Center
Panacee Hospital Rama 2 - Integrative Chronic Disease & Regenerative Center
Thailand, Bangkok
Clinic is certified :
Non-Hodgkin's lymphoma treatment cost in Thailand typically runs from $2,000 / ฿68,000 to $5,000 / ฿170,000 for chemotherapy cycles, while advanced interventions like bone marrow transplantation range from $50,000 / ฿1,700,000 to $80,000 / ฿2,720,000. Total expenses depend on the cancer stage, hospital category, and specific protocol complexity. Patients can achieve 50-80% savings compared to the US. Specialized oncology care is primarily concentrated in Bangkok, Phuket, and Chiang Mai.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Thailand
Bookimed Expert Insight: For complex hematologic cases, JCI-accredited centers like Bumrungrad International Hospital offer the highest value. They utilize AI and digital imaging to manage high international patient volumes from 190 countries. Patients seeking supportive care can integrate cellular therapies at Panacee Hospital Rama 2. This facility combines detoxification with modern oncology protocols at a cellular level. Specialist consultations with Thai Board-certified hematologists, such as Dr. Kodchanut Litleaungdej, ensure expert protocol validation.
| Thailand | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $5,500 / ฿187,000 | from $7,000 / ฿238,000 | from $12,000 / ฿408,000 |
| Chemotherapy for breast cancer | from $3,000 / ฿102,000 | from $1,200 / ฿40,800 | from $15,000 / ฿510,000 |
| Chemotherapy | from $2,000 / ฿68,000 | from $2,430 / ฿82,620 | from $2,500 / ฿85,000 |
| Bone marrow transplantation | from $50,000 / ฿1,700,000 | from $36,000 / ฿1,224,000 | from $140,000 / ฿4,760,000 |
| Autologous bone marrow transplantation | from $40,000 / ฿1,360,000 | from $31,500 / ฿1,071,000 | from $50,000 / ฿1,700,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Non-Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Non-Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Non-Hodgkin's lymphoma treatment journey.
Dr. Kodchanut is a hematologist with specialized training in Non-Hodgkin's lymphoma, working as a pioneer hematologist at Huahin Hospital.
The doctor is an experienced oncologist and oncohematologist with a specialization in bone marrow transplants. They have dedicated their career to advancing treatments in oncology and hematology, focusing on innovative therapies and patient care. The doctor has contributed significantly to clinical research in their field, enhancing treatment protocols and improving patient outcomes. Their work in bone marrow transplantation is particularly notable, with a track record of successful procedures and improved survival rates for patients.
Thailand is a premier destination for Non-Hodgkin lymphoma treatment due to JCI-accredited facilities and rapid diagnostic timelines. Patients access advanced therapies like peripheral blood stem cell transplants and targeted immunotherapy. Specialized hematologists provide Western-standard care at a fraction of the cost found in the US or UK.
Bookimed Expert Insight: Thailand's private hospitals focus on extreme medical efficiency to serve over 1 million patients annually. Data shows major centers like Bumrungrad International manage 500,000+ international cases, meaning they have dedicated systems for fast-tracking pathology reviews. This infrastructure allows patients to receive a confirmed subtype diagnosis and treatment plan much faster than in many national health systems.
Patient Consensus: Patients note that while the medical costs are lower, the real value is avoiding long queues for scans and biopsies. They emphasize the importance of English-speaking staff who help navigate complex logistics during chemotherapy cycles.
Non-Hodgkin lymphoma treatment in Thailand includes advanced chemotherapy, immunotherapy, and stem cell transplantation at JCI-accredited facilities. High-volume centers like Bumrungrad International Hospital utilize PET-CT scans and cytogenetic analysis for precise staging. Specialized teams offer autologous and allogeneic bone marrow transplants for relapsed or high-risk cases.
Bookimed Expert Insight: While chemotherapy is the standard, Thailand stands out for its high-volume hematology units. Bumrungrad International Hospital treats over 1,000,000 patients annually and holds Global Healthcare Accreditation. This high patient volume allows local hematologists like Dr. Kodchanut Litleaungdej to maintain deep expertise in rare NHL subtypes. Choosing these large tertiary centers ensures you have access to medical oncology, radiation, and hematology in a single facility.
Patient Consensus: Patients emphasize the need for a full pathology report to confirm the exact lymphoma subtype before traveling. They note that major Bangkok hospitals are preferred because they house the complete diagnostic and treatment stack in one place.
Find qualified lymphoma specialists in Bangkok by targeting JCI-accredited facilities with dedicated hematology-oncology departments. Look for doctors like Dr. Kodchanut Litleaungdej who hold Thai Board of Hematology certification. Top centers offer advanced diagnostics like bone marrow punctures with cytogenetic analysis and specialized stem cell transplantation.
Bookimed Expert Insight: Lymphoma care in Thailand is highly centralized. While the country has over 150 clinics, major hospitals like Bumrungrad treat over 1,000,000 patients annually. This massive patient volume allows specialists to see rare lymphoma subtypes more frequently than local doctors. Prioritize centers in Bangkok that serve international patients from over 190 countries to ensure seamless communication.
Patient Consensus: Patients emphasize finding a hematologist-oncologist rather than a general oncologist for better precision in blood cancer treatment. Many travelers recommend prioritizing hospital expertise and pathology support over a convenient location near their hotel.
You can often begin oncology consultations and diagnostic workups within 24 to 48 hours in Thailand. Major JCI-accredited centers in Bangkok specialize in rapid access. While specialist meetings happen quickly, chemotherapy or bone marrow transplants usually start after verifying pathology results.
Bookimed Expert Insight: While many seek immediate care, speed depends on hospital volume. Bumrungrad International Hospital manages over 1,000,000 patients annually with 1,300 doctors. This scale allows them to maintain 70 departments for rapid cross-specialty clearance. Smaller centers like Panacee Hospital Rama 2 focus on integrative care with only 40 beds. Choosing a high-capacity hospital is the most reliable way to ensure same-week diagnostics for complex cases like Non-Hodgkin's lymphoma.
Patient Consensus: Patients note that private hospitals are the fastest route for urgent oncology care. Many recommend bringing all previous imaging and medical records to avoid starting the diagnostic process from scratch.
Visa requirements for Thailand depend on your nationality and treatment length. Many citizens enter visa-free for 60 days. Stays exceeding 90 days for complex therapies like bone marrow transplants require a Non-Immigrant Visa (MT). Formal hospital confirmation and proof of funds are mandatory for these applications.
Bookimed Expert Insight: Non-Hodgkin's lymphoma therapy often requires longer stays than initially planned. Bumrungrad International Hospital serves patients from 190 countries and manages heavy international volumes. High-capacity centers like this have dedicated teams to streamline the specific immigration paperwork needed for multi-cycle chemotherapy or stem cell transplants.
Patient Consensus: Patients note that cancer treatment schedules often change. They recommend securing a medical-specific visa early to avoid the stress of last-minute immigration extensions during active recovery.
Thai oncology centers coordinate care through detailed English-language medical reports and digital records. Your treatment team provides chemotherapy protocols, biopsy results, and infusion schedules. This ensures your home doctor manages follow-up blood counts and recovery monitoring effectively after you return.
Bookimed Expert Insight: Coordination gaps often happen because primary doctors at home cannot access proprietary Thai hospital portals. To solve this, Bookimed confirms your oncology team provides a physical and digital record set. This must include specific drug dosages and manufacturer names for medication reconciliation.
Patient Consensus: Patients note they often act as the primary bridge by carrying their own biopsy results and infusion schedules. They emphasize requesting English records early makes follow-up care with home doctors much smoother.
Thai oncologists are highly experienced in treating international patients with Non-Hodgkin lymphoma. Major Bangkok hospitals serve over 1,000,000 patients annually. Half of these arrive from 190 different countries. Specialists often hold international board certifications and use treatments like stem cell transplantation.
Bookimed Expert Insight: Thailand’s efficiency is a major draw for Australian patients facing long public waitlists. Data shows the timeline from diagnosis to chemotherapy often takes 7 to 8 weeks. Clinics like Panacee Hospital also offer integrative care. This combines modern medicine with regenerative cell therapy.
Patient Consensus: Patients find the private hospital system in Thailand accessible and well-equipped for aggressive cancers. They suggest securing medical travel clearance early. Standard insurance often excludes pre-existing lymphoma conditions.
Bumrungrad International Hospital and Bangkok Hospital lead Thailand's treatment for Non-Hodgkin's lymphoma. These Bangkok-based centres offer JCI-accredited care, using immunotherapy and bone marrow transplants. Specialist oncologists provide precise diagnosis and advanced protocols. Most facilities feature dedicated international departments to manage patient logistics seamlessly.
Bookimed Expert Insight: Bumrungrad International Hospital's massive patient volume of 1,000,000 people annually is a key quality indicator. Half of these patients travel from 190 different countries. This high volume means their medical teams have handled nearly every lymphoma subtype. Australian patients benefit from their Global Healthcare Accreditation, which focuses specifically on international care standards.
Patient Consensus: Patients find that Thailand's tropical climate requires extra care during chemo recovery. Many recommend staying hydrated and avoiding direct sun to protect sensitive skin. Successful treatment pathways often begin with detailed characterisation of the specific lymphoma type.
Thailand provides comprehensive care for diverse Non-Hodgkin lymphoma subtypes. Specialists treat B-cell lymphomas like diffuse large B-cell lymphoma and follicular lymphoma. They also manage T-cell types and extranodal MALT lymphoma. Major Bangkok hospitals use chemotherapy, immunotherapy, and bone marrow transplants. This helps achieve high survival rates.
Bookimed Expert Insight: Many local clinics focus on basic care. However, major Bangkok centres operate on a massive scale. Bumrungrad International Hospital alone treats patients from over 190 countries. This high volume means oncohaematologists like Dr Kodchanut Litleaungdej develop deep experience. They see diverse lymphoma presentations. Patients benefit from this global expertise. It is combined with integrated cell therapies found in specialised Thai regenerative centres.
Patient Consensus: Patients note that, in Thailand, Non-Hodgkin lymphoma requires precise characterisation. It must be classified as B-cell or T-cell. They appreciate the availability of diverse treatment protocols. These include stem cell options for aggressive cases.
A bone marrow transplant for Non-Hodgkin's lymphoma in Thailand gives access to JCI-accredited facilities. These facilities have no waiting lists. Specialist centres provide autologous and allogeneic transplants using peripheral blood stem cell therapy. These procedures typically treat relapsed or aggressive cases after initial chemotherapy fails.
Bookimed Expert Insight: Thailand's infrastructure for complex haematology is driven by massive volume. Bumrungrad International Hospital alone serves over 1 million patients annually. Our data show a distinct advantage for Australians. Major Bangkok clinics hold ISO 9001:2015 and JCI certifications. These standards match Australian safety expectations. This is vital for high-risk procedures like stem cell reinfusion.
Patient Consensus: Patients note that recovery requires staying near the hospital for at least 100 days. This is to monitor immune recovery. While Thailand offers high-quality diagnostic tools, the long-term stay is a significant commitment. It is a larger commitment than first-line chemotherapy.
Non-Hodgkin lymphoma treatment in Thailand typically requires an initial stay of 2 to 4 weeks. This covers diagnosis, staging scans, and the first chemotherapy cycle. Complete protocols often involve 3 to 4 months of treatment cycles with periodic hospital admissions.
Bookimed Expert Insight: Thailand is a major hub for haematology-oncology. Bumrungrad International Hospital alone serves 500,000 international patients annually. Specialists like Dr Kodchanut Litleaungdej have advanced training in haematology from leading Thai universities. This high volume allows clinics to speed up diagnostics. They can often move from biopsy to first chemo in under 3 weeks.
Patient Consensus: Patients note that the first month is the most intensive while waiting for staging results. Most suggest planning for a 3-week initial stay in Bangkok first. Then they can discuss if their Australian GP can coordinate follow-up chemo cycles.